In two , open-label , 2-year studies patients poorly controlled on a sulphonylurea were randomised to adjunctive EXU or metformin ( study 1 ) and patients poorly controlled on metformin were randomised to adjunctive EXU or the sulphonylurea , glibenclamide ( study 2 ) .
